This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Meridian Bioscience Inc (VIVO)

NASDAQ: Health Care

Company Balance Sheet
Sep 2013 Sep 2012 Sep 2011 Sep 2010
Cash and Equivalents 44.28M 31.59M 23.63M 37.88M
Receivables 26.18M 24.18M 24.84M 22.06M
Inventories 34.84M 31.68M 32.69M 27.96M
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 114.09M 96.59M 90.35M 94.02M
Property, Plant & Equipment, Gross 67.09M 63.22M 60.51M 56.41M
Accumulated Depreciation & Depletion 41.00M 37.07M 33.97M 33.69M
Property, Plant & Equipment, Net 26.09M 26.16M 26.54M 22.72M
Intangibles 8.06M 10.26M 10.95M 13.33M
Other Non-Current Assets 4.57M 1.27M 4.53M 1.24M
Total Non-Current Assets 62.66M 64.79M 65.14M 60.76M
Liabilities & Shareholder Equity
Total Assets 176.75M 161.38M 155.49M 154.78M
Accounts Payable 5.59M 5.79M 5.55M 4.47M
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 979.00K 1.59M 789.00K 809.00K
Total Current Liabilities 21.70M 18.46M 15.26M 14.15M
Long Term Debt 0.00 0.00 0.00 0.00
Deferred Income Taxes 0.00 171.00K 1.70M 3.28M
Other Non-Current Liabilities 0.00 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 0.00 171.00K 1.70M 3.28M
Total Liabilities 21.70M 18.63M 16.97M 17.42M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 155.04M 142.75M 138.52M 137.36M
Common Par 0.00 0.00 0.00 0.00
Additional Paid In Capital 107.41M 102.44M 100.01M 94.53M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings 46.89M 40.21M 38.06M 42.18M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 745.00K 95.00K 449.00K 655.00K
Total Capitalization 155.04M 142.75M 138.52M 137.36M
Total Equity 155.04M 142.75M 138.52M 137.36M
Total Liabilities & Stock Equity 176.75M 161.38M 155.49M 154.78M
Total Common Shares Outstanding 41.52M 41.28M 41.24M 40.65M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 41.23M 41.08M 40.72M 40.52M
Diluted Weighted Shares Outstanding 41.90M 41.61M 41.36M 41.15M
Number of Employees 550 510 525 498
Number of Part-Time Employees 0 0 0 0

VIVO Meridian Bioscience Inc

Analysts Ratings for VIVO

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 1 1 1 1
Moderate Buy 1 1 1 1
Hold 4 4 4 4
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1

Brokerage Partners

VIVO Chatter

Select the service that is right for you!

Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs